About: John Wayne Cancer Institute

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: John Wayne Cancer Institute Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American nonprofit organization

Attributes	Values
rdf:type	Item
description	American nonprofit organization (en) amerikanische Non-Profit-Organisation (de) американська неприбуткова організація (uk)
IRS Employer Identification Number	wds:Q54559592-909D20DF-1DE0-4709-BB72-E49BD5D38E97
IRS Employer Identification Number	95-4291515
rdfs:label	John Wayne Cancer Institute (en)
skos:prefLabel	John Wayne Cancer Institute (en)
name	John Wayne Cancer Institute (en)
instance of	wds:Q54559592-4ED3551A-4C24-4188-A881-E434ADA6E973
instance of	nonprofit organization
country	wds:Q54559592-5A81F58B-CD50-4131-B926-D7C6AECE3658
country	United States of America
Ringgold ID	wds:Q54559592-E40A6C8A-0F0D-446B-848D-6395DD0DA4D5
Ringgold ID	20279
Charity Navigator ID	wds:Q54559592-1FD7EBAB-4871-4A35-AEF0-70A60A753C8B
Charity Navigator ID	3956
official website	wds:Q54559592-3B97A3A6-C7A0-47BD-BC8E-263B42D033B7
official website	http://california.providence.org/john-wayne/
total revenue	wds:Q54559592-449C062F-FF1F-4180-9F46-32965F8CB351
total revenue	9769682 (xsd:decimal)
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q54559592
is research site of	Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma ABI-009 (Nab-Rapamycin) in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma Transsphenoidal Extent of Resection Study Phase IIB TL + YCWP + DC in Melanoma Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma Trial of pIL-12 Electroporation Malignant Melanoma Studying Lymph Nodes in Patients With Stage II Colon Cancer A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (ECHO-208) POA Prospective Repository Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200) Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas Stage IV Surgery Versus Best Medical Therapy Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer TR(ACE) Assay Clinical Specimen Study Irofulven in Treating Patients With Stage IV Melanoma Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma Minimally Invasive Groin Dissection for Melanoma Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer Pemetrexed for the Treatment of Chordoma Safety Study of Afatinib for Brain Cancer A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Multicenter Selective Lymphadenectomy Trial II (MSLT-II) Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA) A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas Nutrition Intervention in Treating Women With Breast Cancer A Study to Assess Safety and Efficacy of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-PD-1 Treatment
is research site of	wds:Q62110939-8B5BDD63-3392-4A78-8520-EF20F5B69CC6 wds:Q63401841-1A1CE007-D202-4702-B2EE-E3EDE08C5FB9 wds:Q64805220-AD501100-EB87-4705-A993-248D11E8CBFB wds:Q65349226-CA62FE41-7353-4CCB-8EB6-AE16C934BBFB wds:Q65351141-F7EA4096-A61E-46A5-A06E-118C96534345 wds:Q66035100-671C32CE-B85C-4173-851E-33F2C2B84968 wds:Q64614213-40BC4A8B-B2E7-4CA5-94B6-3C80856E330B wds:Q64674158-9A748EED-8D89-4B6C-85E4-3EF9F72B7F6F wds:Q61957512-6B8B0185-C3E3-4BB1-8F74-BF7ED4815B1F wds:Q64665144-D1668443-9581-4409-9F0F-9AEA6CBD1480 wds:Q58407652-3BACCF1A-6785-4DDC-9AD0-8A7049865150 wds:Q66027268-464C60ED-8F72-4DA5-BE23-59B66024109C wds:Q64789020-7FABE749-164F-4696-A802-4DF8EF0ED7DC wds:Q63534462-2D9EC639-B7AD-41CD-825F-04A7D8F975DE wds:Q64792526-9479B24A-69A5-4ECC-8698-DF3346900005 wds:Q64715996-6873DD06-D33B-4518-8217-F53D39E1B612 wds:Q66037961-F0D9730E-1478-4143-BB62-181B82546987 wds:Q66039820-E69F3AED-0C73-407C-A26D-B8BE8487A8E9 wds:Q63599795-228AD506-328C-4D5B-8C6D-BAC82974E13D wds:Q63590802-A28FF291-D640-4175-A724-CF5B89761EEC wds:Q64150266-B1086AFE-1067-49DB-988D-8E09FE1A7819 wds:Q64659542-2532A63D-0235-4B13-BDD3-C611D7DCB365 wds:Q64186309-E9E9C963-5521-4677-AA1D-F3F17109E409 wds:Q65333171-86760152-BE92-4C9B-AA08-73DB2E8C5D0B wds:Q99529681-D64E750B-2AFD-474E-885B-60E6DE7AFFAD wds:Q66077434-0026DA96-CE2A-4FE5-B513-2D31DF7D1649 wds:Q66080435-9E655661-06E3-4330-8379-077BFB843DC5 wds:Q62110609-4A0D1E2C-A0EB-44BC-8CC9-E64506CD7E23 wds:Q61864701-EF5C38E6-0FD2-4021-B81A-06E8432AEB75 wds:Q66032474-029DE83F-9887-41A3-9268-4003A6BFD17F wds:Q66036947-6C3E60BE-B4D8-4D5F-A507-468EE7754A6C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software